{"id":985699,"date":"2026-07-28T10:05:07","date_gmt":"2026-07-28T14:05:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/new-humana-healthcare-researchstudy-finds-favorable-selection-in-medicare-advantage-is-substantially-lower-than-medpac-estimates\/"},"modified":"2026-07-28T10:05:07","modified_gmt":"2026-07-28T14:05:07","slug":"new-humana-healthcare-researchstudy-finds-favorable-selection-in-medicare-advantage-is-substantially-lower-than-medpac-estimates","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/new-humana-healthcare-researchstudy-finds-favorable-selection-in-medicare-advantage-is-substantially-lower-than-medpac-estimates\/","title":{"rendered":"New Humana Healthcare ResearchStudy Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates"},"content":{"rendered":"

<\/p>\n

New Humana Healthcare Research<\/b>Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates<\/b><\/p>\n

Published in Health Affairs Scholar, the study finds that a single methodological refinement reduces favorable selection estimates by 42%-65%, suggesting a smaller impact on MA payments than previous analyses have indicated<\/i><\/p>\n

LOUISVILLE, Ky.–(BUSINESS WIRE<\/a>)–
\nA new study from Humana Healthcare Research (HHR), published in Health Affairs Scholar<\/i><\/a>, finds that favorable selection in Medicare Advantage (MA) may be significantly lower than commonly cited estimates suggest. Favorable selection refers to the extent to which MA enrollees incur lower costs than predicted after risk adjustment and is an important factor in MA payment policy debates. The study found that a single methodological refinement substantially reduced favorable selection estimates compared with previous analyses by MedPAC and others.<\/p>\n

Key HHR Study Findings<\/b><\/p>\n